Have a personal or library account? Click to login
Isorhynchophylline Inhibits NLRP3 Inflammasome and Improves Gestational Diabetes Cover

Isorhynchophylline Inhibits NLRP3 Inflammasome and Improves Gestational Diabetes

Open Access
|Mar 2025

References

  1. Basil B, Mba IN, Myke-Mbata BK et al. (2024) A first trimester prediction model and nomogram for gestational diabetes mellitus based on maternal clinical risk factors in a resource-poor setting. BMC Pregnancy Childbirth 24:346. https://doi.org/10.1186/s12884-024-06519-7
  2. Cao M, Bu C, Zhang J et al. (2022) Exosomal circular RNA hsa_ circ_0046060 of umbilical cord mesenchymal stromal cell ameliorates glucose metabolism and insulin resistance in gestational diabetes mellitus via the miR-338-3p/G6PC2 axis. Int J Endocrinol 2022:9218113. https://doi.org/10.1155/2022/9218113
  3. Cui SS, Zhang P, Sun L et al. (2023) Mucin1 induced tropho-blast dysfunction in gestational diabetes mellitus via Wnt/beta-catenin pathway. Biol Res 56:48. https://doi.org/10.1186/s40659-023-00460-3
  4. Fu Q, Dong W, Ge D et al. (2023) Supercritical fluid chromatography based on reversed-phase/ion chromatography mixed-mode stationary phase for separation of spirooxindole alkaloids. J Chromatogr A 1705:464163. https://doi.org/10.1016/j.chroma.2023.464163
  5. Li Z, Shi H, Li Y et al. (2022) Isorhynchophylline ameliorates the progression of osteoarthritis by inhibiting the NF-kappaB pathway. Eur J Pharmacol 924:174971. https://doi.org/10.1016/j.ejphar.2022.174971
  6. Liu Y, Wei Y, Wu L et al. (2022) Fructose induces insulin resistance of gestational diabetes mellitus in mice via the NLRP3 inflammasome pathway. Front Nutr 9:839174. https://doi.org/10.3389/fnut.2022.839174
  7. Maiorino MI, Bellastella G, Giugliano D et al. (2017) Cooling down inflammation in type 2 diabetes: How strong is the evidence for cardiometabolic benefit? Endocrine 55:360–365. https://doi.org/10.1007/s12020-016-0993-7
  8. Milionis C, Ilias I, Koukkou E (2024) Gestational diabetes mellitus may predispose to metabolic dysfunction-associated steatotic liver disease. World J Hepatol 16:860–862. https://doi.org/10.4254/wjh.v16.i5.860
  9. Ray GW, Zeng Q, Kusi P et al. (2024) Genetic and inflammatory factors underlying gestational diabetes mellitus: A review. Front Endocrinol (Lausanne) 15:1399694. https://doi.org/10.3389/fendo.2024.1399694
  10. Sweeting A, Wong J, Murphy HR et al. (2022) A clinical update on gestational diabetes mellitus. Endocr Rev 43:763–793. https://doi.org/10.1210/endrev/bnac003
  11. Wang D, Sun M, Liu Y et al. (2023c) Isorhynchophylline regulates the circadian rhythm of the hypothalamus in spontaneously hypertensive rats to treat hypertension. Curr Pharm Des 29:139–148. https://doi.org/10.2174/1381612829666221222115134
  12. Wang D, Yu X, Gao K et al. (2024) Sweroside alleviates pressure overload-induced heart failure through targeting CaMK-delta to inhibit ROS-mediated NF-kappaB/NLRP3 in cardiomyocytes. Redox Biol 74:103223. https://doi.org/10.1016/j.redox.2024.103223
  13. Wang J, Wang X, Zhang M et al. (2023b) The activation of spliced X-box binding protein 1 by isorhynchophylline therapy improves diabetic encephalopathy. Cell Biol Toxicol 39:2587–2613. https://doi.org/10.1007/s10565-022-09789-z
  14. Wang LH, Gu ZW, Li J et al. (2023a) Isorhynchophylline inhibits inflammatory responses in endothelial cells and macrophages through the NF-kappaB/NLRP3 signaling pathway. BMC Complement Med Ther 23:80. https://doi.org/10.1186/s12906-023-03902-3
  15. Wu Y, Bian Y, Fei J et al. (2023) Isorhynchophylline attenuates proliferation and migration of synovial fibroblasts via the FOXC1/beta-catenin axis. Autoimmunity 56:2289868. https://doi.org/10.1080/08916934.2023.2289868
  16. Yang H, Liu D, Wang Y (2023a) Physalin A exerts neuroprotective effects: Inhibition of OGD/R-induced cellular pyroptosis and inflammatory responses in nerve cells. Signa Vitae 19:168–174. https://doi.org/10.22514/sv.2023.111
  17. Yang Y, Feng Q, Luan Y et al. (2023b) Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases. Front Pharmacol 14:1229297. https://doi.org/10.3389/fphar.2023.1229297
  18. Yangzhong X, Hua S, Wen Y et al. (2024) NLRP3 Inflammasome triggers inflammation of obstructive sleep apnea. Curr Mol Med. https://doi.org/10.2174/0115665240294605240426123650
  19. Zhao H, Li X, Yang L et al. (2021) Isorhynchophylline relieves ferroptosis-induced nerve damage after intracerebral hemorrhage via miR-122-5p/TP53/SLC7A11 pathway. Neurochem Res 46:1981–1994. https://doi.org/10.1007/s11064-021-03320-2
  20. Zheng Q, Zhang Y, Zhao Z et al. (2021) Isorhynchophylline ameliorates paraquat-induced acute kidney injury by attenuating oxidative stress and mitochondrial damage via regulating toll-interacting expression. Toxicol Appl Pharmacol 420:115521. https://doi.org/10.1016/j.taap.2021.115521
  21. Zhou Z, Hu C, Cui B et al. (2024) Ginsenoside Rg1 suppresses pyroptosis via the NF-kappaB/NLRP3/GSDMD pathway to alleviate chronic atrophic gastritis in vitro and in vivo. J Agric Food Chem. https://doi.org/10.1021/acs.jafc.4c01271
  22. Zhu X, Hou Q, Zhang L et al. (2023) Isorhynchophylline improves lipid metabolism disorder by mediating a circadian rhythm gene Bmal1 in spontaneously hypertensive rat. Phytother Res 37:5991–6005. https://doi.org/10.1002/ptr.8015
Language: English
Submitted on: Oct 9, 2024
Accepted on: Jan 17, 2025
Published on: Mar 14, 2025
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Li Pu, Li Chen, Kun Yu, Yueming Zhang, Caifeng Wang, Feizhou Jiang, Jia Shi, Jingjing Meng, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.